Andreas Diefenbach, MD, PhD

University of Mainz
Mainz Germany
Biographical Sketch: Andreas Diefenbach is Professor and Chair of Medical Microbiology at the Research Centre of Immunology, University of Mainz. He graduated in Microbiology and Immunology from the University of Erlangen (1998) and obtained postdoctoral training at the Department of Molecular and Cellular Biology, University of California Berkeley (1999-2002). Prior to joining the University of Mainz, he was an Assistant Professor at the Skirball Institute of Biomolecular Medicine, New York University (2003-2006) and a Full Professor at the University of Freiburg (2006-2013). His current research interests include the transcriptional circuitry that control fate decisions of innate lymphoid cells and their adaptation by environmental factors (microbiota, nutrients). As a Physician Scientist, Andreas won grant support by the Howard Hughes Medical Institute, by the European Research Council, and by the Deutsche Forschungsgemeinschaft (DFG). He is the coordinator of the DFG Priority Program (“Innate Lymphoid Cells”). He was awarded with the Main Scientific Prize of the German Society of Hygiene and Microbiology.

Any personal financial relationships? No

1. I will insure balance, independence, objectivity, and scientific rigor in my role in the planning, development or presentation of this CME activity.

2. I will comply with the requirements to protect health information under the Health Insurance Portability & Accountability Act of 1996 (HIPAA).

3. I will disclose any discussion or reference to unapproved or unlabeled uses of therapeutic agents or products.

4. I have input my full name below as attestation of agreement with declaration statements. Marking the check box and indicating my name is in lieu of signature and is considered an "e-signature".

Signed on 04/27/2015 by Andreas Diefenbach

Papers:
Innate Lymphoid Cells in the Protection of Mucosal Barriers

	1. I will insure balance, independence, objectivity, and scientific rigor in my role in the planning, development or presentation of this CME activity.
	2. I will comply with the requirements to protect health information under the Health Insurance Portability & Accountability Act of 1996 (HIPAA).
	3. I will disclose any discussion or reference to unapproved or unlabeled uses of therapeutic agents or products.
	4. I have input my full name below as attestation of agreement with declaration statements. Marking the check box and indicating my name is in lieu of signature and is considered an "e-signature".